Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MDSO

Medidata Solutions (MDSO) Stock Price, News & Analysis

Medidata Solutions logo

About Medidata Solutions Stock (NASDAQ:MDSO)

Advanced Chart

Key Stats

Today's Range
$92.21
$92.26
50-Day Range
$91.79
$92.25
52-Week Range
$60.10
$98.60
Volume
7.30 million shs
Average Volume
1.24 million shs
Market Capitalization
$5.76 billion
P/E Ratio
96.06
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company was founded in 1999 and is headquartered in New York, New York.

Receive MDSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medidata Solutions and its competitors with MarketBeat's FREE daily newsletter.

MDSO Stock News Headlines

MDSO announce new non-emergency number
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
See More Headlines

MDSO Stock Analysis - Frequently Asked Questions

Medidata Solutions Inc (NASDAQ:MDSO) released its quarterly earnings results on Monday, July, 22nd. The company reported $0.48 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.31. The business's revenue was up 15.8% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medidata Solutions investors own include Meta Platforms (META), NVIDIA (NVDA), Applied Materials (AMAT), Salesforce (CRM), Gilead Sciences (GILD), Bristol-Myers Squibb (BMY) and Allergan (AGN).

Company Calendar

Last Earnings
7/22/2019
Today
4/24/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Prepackaged Software
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:MDSO
Fax
N/A
Employees
1,998
Year Founded
N/A

Profitability

Trailing P/E Ratio
96.06
Forward P/E Ratio
118.23
P/E Growth
6.95
Net Income
$51.92 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$635.70 million
Cash Flow
$1.69 per share
Price / Cash Flow
54.55
Book Value
$10.32 per share
Price / Book
8.94

Miscellaneous

Free Float
N/A
Market Cap
$5.76 billion
Optionable
Optionable
Beta
1.22
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:MDSO) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners